(Q51732242)

English

Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment.

scientific article published on 18 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Sung-Hoon Park

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Chae-Gi Kim

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Ji-Young Kim

3

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Jung-Yoon Choe

4

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

publication date

18 October 2007

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Rheumatology International

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

28

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

5

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

475-477

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

https://scigraph.springernature.com/pub.10.1007/s00296-007-0467-6

0 references

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of lymphoma development in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis and lymphoma: risky business for B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of Epstein-Barr virus infection in patients with immunodeficiency disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis and malignant lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17943259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-007-0467-6

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17943259

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51732242&oldid=1509223040"